Using targeted proteomics tools within a set of various cancer models we describe here the discovery and characterization of a composite phosphorylation signature associated with tumor addiction to four distinct oncogenes, MET, EGFR, ALK and BRAF. The gene discussed is EGFR; the disease is cancer.